Caitlin Cronin
Stock Analyst at Canaccord Genuity
(4.15)
# 507
Out of 5,130 analysts
47
Total ratings
51.43%
Success rate
17.71%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Caitlin Cronin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Maintains: Buy | $105 → $112 | $94.47 | +18.56% | 3 | Jan 9, 2026 | |
| ENOV Enovis | Maintains: Buy | $58 → $50 | $29.68 | +68.46% | 4 | Dec 17, 2025 | |
| INMD InMode | Maintains: Hold | $16 → $15 | $14.44 | +3.88% | 6 | Dec 17, 2025 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $72 → $85 | $68.34 | +24.38% | 3 | Dec 17, 2025 | |
| AXGN Axogen | Maintains: Buy | $27 → $37 | $33.51 | +10.41% | 8 | Dec 5, 2025 | |
| TELA TELA Bio | Maintains: Buy | $7 → $4 | $1.10 | +265.30% | 5 | Nov 18, 2025 | |
| SNN Smith & Nephew | Maintains: Hold | $36 → $34 | $33.57 | +1.28% | 4 | Nov 11, 2025 | |
| ATEC Alphatec Holdings | Maintains: Buy | $20 → $25 | $22.65 | +10.38% | 5 | Oct 31, 2025 | |
| VCEL Vericel | Maintains: Buy | $61 → $58 | $38.56 | +50.41% | 4 | Aug 1, 2025 | |
| BVS Bioventus | Maintains: Buy | $15 | $8.03 | +86.80% | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $5.65 | -29.20% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $130 | $92.85 | +40.01% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $270 → $12 | $2.61 | +359.77% | 1 | Nov 14, 2023 |
Globus Medical
Jan 9, 2026
Maintains: Buy
Price Target: $105 → $112
Current: $94.47
Upside: +18.56%
Enovis
Dec 17, 2025
Maintains: Buy
Price Target: $58 → $50
Current: $29.68
Upside: +68.46%
InMode
Dec 17, 2025
Maintains: Hold
Price Target: $16 → $15
Current: $14.44
Upside: +3.88%
Establishment Labs Holdings
Dec 17, 2025
Maintains: Buy
Price Target: $72 → $85
Current: $68.34
Upside: +24.38%
Axogen
Dec 5, 2025
Maintains: Buy
Price Target: $27 → $37
Current: $33.51
Upside: +10.41%
TELA Bio
Nov 18, 2025
Maintains: Buy
Price Target: $7 → $4
Current: $1.10
Upside: +265.30%
Smith & Nephew
Nov 11, 2025
Maintains: Hold
Price Target: $36 → $34
Current: $33.57
Upside: +1.28%
Alphatec Holdings
Oct 31, 2025
Maintains: Buy
Price Target: $20 → $25
Current: $22.65
Upside: +10.38%
Vericel
Aug 1, 2025
Maintains: Buy
Price Target: $61 → $58
Current: $38.56
Upside: +50.41%
Bioventus
Mar 17, 2025
Maintains: Buy
Price Target: $15
Current: $8.03
Upside: +86.80%
Nov 14, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $5.65
Upside: -29.20%
Feb 23, 2024
Reiterates: Hold
Price Target: $130
Current: $92.85
Upside: +40.01%
Nov 14, 2023
Downgrades: Hold
Price Target: $270 → $12
Current: $2.61
Upside: +359.77%